Who qualifies for Accutane (and who doesn’t)?
Who qualifies for Accutane under the 2024 AAD guideline and FDA label: hormonal acne, men, body acne, adults, and why blackheads and pores don’t. Read more →

Tretinoin for men: what it does, what the first weeks look like, and how to handle shaving, aftershave and sun.
Who qualifies for Accutane under the 2024 AAD guideline and FDA label: hormonal acne, men, body acne, adults, and why blackheads and pores don’t. Read more →
When telehealth Accutane (isotretinoin) is a fit and when in-person dermatology is the better route, plus what iPledge requires either way. Read more →
Does Accutane work for hormonal acne, and does a low dose suit mild acne? What the FDA label, the AAD and verified trials say. Read more →
Second course of Accutane: verified relapse rates, why total dose beats daily dose, and why a low-dose second course means more iPledge months. Read more →
Low dose Accutane side effects, effect by effect: what studies show gets milder, what stays the same at any dose, and why iPledge never shrinks. Read more →
What low-dose isotretinoin results look like month by month, what one 50-patient study measured, and why a gentler course means more iPledge cycles, not fewer. Read more →
What microdosing Accutane actually means, what one clinical study found, and the detail every guide skips: your iPledge requirements don’t shrink with your dose. Read more →
Low dose Accutane vs standard isotretinoin: a dermatology-informed breakdown of dosing, side effects, timelines, cost, and who each approach is right for. Read more →
Cleansing, moisturizer, sunscreen and taking doxycycline, tretinoin or spironolactone as directed: what the AAD, the Doryx MPC label and MedlinePlus say about daily acne habits. Read more →